| EPA0053 | Identification of novel PTPN1/PTPN2 inhibitors to target latent HIV reservoirs | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0054 | P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0055 | Developing an ultrasensitive assay to quantify HIV-1 envelope protein in different matrixes | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0056 | HIV proviral reactivation is impaired in effector memory CD4+ T cells by immunometabolic reprogramming with dasatinib | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0057 | Mauritian cynomolgus macaques are a unique model of post-treatment control of SIV replication | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0058 | Impact of IL-15 neutralization on neuropathogenesis in acute HIV/SIV infection | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0059 | Effect of sex and HCV on microRNA profile as a biomarker of HIV viral reservoir | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0060 | Distinct detection of intact and defective proviruses for people living with HIV subtype B and C | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0061 | Young adults with perinatally-acquired HIV from Argentina present differential IPDA-determined HIV reservoir composition and immune phenotype: distinctive strategies needed for HIV cure? | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0062 | Viral rebound dynamics in SHIV-infected infant macaques are predicted by distinct immunovirologic features measured before and after one year of antiretroviral therapy | E-poster | Understanding and targeting persistent HIV reservoirs |